Evidence map›Paper›PMID 42258113›Full record

ArticleAIDS and behavior2026

High Uptake of HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men Recruited via Geosocial Networking Applications and Community Outreach in Paris, France.

Anton Eremin, Thomas Grunemwald, Romain Palich, Stéphane Morel, Antoine Elisa, Dominique Pataut, Thibaut Jedrzejewski, Yasmine Dudoit, Rachid Agher, Marie Costa and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anton EreminAix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France. drantoneremin@gmail.com.ORCID http://orcid.org/0000-0001-6232-1764
Thomas GrunemwaldLe 190 Sexual Health Center, Paris, France.
Romain PalichParis Cité University, Immunology and Infectious Diseases Department, Hôtel-Dieu Hospital, AP-HP, Paris, France.ORCID http://orcid.org/0000-0003-0047-0101
Stéphane MorelAIDES, Pantin, France.
Antoine ElisaAIDES, Pantin, France.
Dominique PatautLe 190 Sexual Health Center, Paris, France.
Thibaut JedrzejewskiLe 190 Sexual Health Center, Paris, France.
Yasmine DudoitSorbonne University, Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (IPLESP), Inserm 1136, Paris, France.
Rachid AgherSorbonne University, Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (IPLESP), Inserm 1136, Paris, France.
Marie CostaAIDES, Pantin, France.
David MichelsAIDES, Pantin, France.
Annie VelterAix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Luis Sagaon-TeyssierAix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.ORCID http://orcid.org/0000-0001-7318-6596
Michel OhayonLe 190 Sexual Health Center, Paris, France.
Christine KatlamaSorbonne University, Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (IPLESP), Inserm 1136, Paris, France.ORCID http://orcid.org/0000-0002-5093-4800

Funding

Aix-Marseille Institute of Public Health Sciences (ISSPAM) and Santé publique France (SpF) Aix-Marseille Institute of Public Health Sciences (ISSPAM) and Santé publique France (SpF)Ministère de l'Economie, du Redressement Productif et du Numérique GIRCI, AAP ReSP-IR 2023ViiV Healthcare ViiV Healthcare
6 · The paper itself

Abstract

Despite free access in France, uptake of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) remains insufficient, particularly among younger and migrant subpopulations. This study describes a community-based program linking outreach via geosocial/sexual networking applications and community venues to same-day PrEP access at a sexual health center in Paris. MSM and transgender individuals aged ≥ 18 years were recruited and referred to the Le 190/Le SPOT sexual health center. At baseline, they received HIV/STI testing and, depending on results, initiation of PrEP, post-exposure prophylaxis (PEP), or antiretroviral therapy. Sociodemographic, behavioral, and clinical data were collected at baseline and follow-up (months 1, 3, 6). The primary outcome was PrEP uptake among eligible participants (HIV-negative, not on PrEP, without PEP indication); associated factors were assessed using Firth's penalized logistic regression. Between July 2023 and December 2024, 209 individuals were enrolled; 86% were recruited via apps, the median age was 31 years (IQR 26-41), and 47% were born outside France. Participants reported a median of six sexual partners (IQR 3-15) in the past three months; 73% had been tested for HIV/STI in the past year. Fourteen participants (7%) were living with HIV, including five newly diagnosed individuals. Among 164 PrEP-eligible participants, 118 (72%) initiated PrEP at baseline; 82/118 (70%) were retained at month 6. In multivariable analysis, uptake was associated with reporting ≥ 6 partners in the past three months and HIV/STI testing in the past year. These findings indicate high PrEP uptake among individuals presenting to care after community outreach, including younger and foreign-born MSM typically underrepresented in PrEP programs.

Indexed as

Geosocial networking applicationsHIVMSMOutreachPrEP

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.